International Clinical Trial: A Single-Arm, Single-Center, Phase II Exploratory Study of Adbelimab in Combination with Targeted Therapy and Chemotherapy for the Conversion Therapy of Patients with Unresectable MSS Colorectal Cancer with Liver Metastases

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122531) titled 'A Single-Arm, Single-Center, Phase II Exploratory Study of Adbelimab in Combination with Targeted Therapy and Chemotherapy for the Conversion Therapy of Patients with Unresectable MSS Colorectal Cancer with Liver Metastases' on April 14.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Colorectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-15

Target Sample Size: Experimental group:37;

Countries of Recruitment: China

To know more, ...